Brind.

Flagship Pioneering is the largest shareholder of Seres Therapeutics.

1 report, 1 independent Updated Jul 21
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Flagship Pioneering is the largest shareholder of Seres Therapeutics.

Who's involved

What this event is mainly about

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • Simply Wall St.Seres Therapeutics, Inc.'s (NASDAQ:MCRB) top owners are individual investors with 51% stake, while 23% is held by institutions The considerable ownership by individual investors in Seres Therapeutics